One elopement is one too many for busy tech innovators.
Hearing aid manufacturers still need to listen up about seniors’ specific needs: report
By
Aaron Dorman
Mar 05, 2024
Many seniors could benefit from larger, more customized hearing aids, which are easier to manipulate, experts noted.
‘Dementia-capable’ workforce a key to changing trajectory of disease: report
By
Lois A. Bowers
Oct 30, 2019
Building a “dementia-capable” workforce across the care continuum is one of five recommendations that could change the trajectory of the disease, which could affect 13 million people and lead to an...
Statin use not tied to cognitive decline, dementia in seniors
Jun 22, 2021
No association was seen for statin use versus nonuse with dementia, mild cognitive impairment or changes in cognitive function over time.
AI ‘promising’ for use in geriatrics, but ethical concerns remain, researchers say
By
Aaron Dorman
Sep 22, 2023
A new meta-study on using AI within geriatrics praises AI as a “valuable asset” but still warns about the need for future research and potential ethical concerns.
App aims to improve communication, care coordination
By
Lois A. Bowers
Nov 16, 2017
A personal experience with a relative with dementia inspired high school student Logan Wells and his family to develop an app to help improve communication and the coordination of care among professional...
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Smorgasbord of health tech innovations presented in Finland; country’s senior centers reaping benefits
By
Aaron Dorman
Aug 03, 2023
Many emerging healthcare technologies aimed at seniors were on display at Finland’s recent Radical Health Festival.
1 in 10 older adults have dementia, and that’s going to grow with aging population boom
By
Kimberly Bonvissuto
Oct 25, 2022
The first nationally representative study of cognitive impairment and dementia in more than 20 years found nearly one in 10 US older adults has dementia, and 22% have mild cognitive impairment.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.